There’s a lot of buzz these days about Precision Medicine, the Moonshot, new targeted therapies and immunotherapies but one thing has not changed…. a cancer treatment’s efficacy and safety must be tested in a clinical trial. Historically only 3-5% of adult cancer patients participate in clinical trials. Genomic medicine creates even more challenges for the […]
Read the Full ArticleCategories:
Early Engagement, Patient Advocate, Patient Centricity, Patient Engagement, R&D, StrategyOn November 12 – 13, over 300 individuals representing pharmaceutical companies, biotechs, and payers and patient advocates gathered in Geneva, Switzerland. Over 100 attendees represented patient advocacy organizations, a record for the Congress. On day one, following the opening remarks, we heard from Ségolène Aymé, coordinator and scientific secretariat for the International Rare Diseases Research […]
Read the Full ArticleThis is the second in a two-part series about involving patients and advocacy groups in clinical trials. The first blog entry, can be found here: Patient advocate engagement in early stage development. Since 2010, MK&A and The Brooks Group have produced a syndicated market research report for the pharmaceutical industry to provide competitive benchmarking and […]
Read the Full ArticleTwice a year, MK&A associates attend an offsite meeting to plan, improve our skills and stay up-to-date on the latest in patient, professional and consumer trends and research. At our March meeting we invited a panel of advocates to discuss why and how their organizations are investing time and resources in the development process of […]
Read the Full ArticleAs the patient experience and its value increases in significance for regulators and payers, leading companies will foster exceptional advocacy relations. For many years, patient organizations and pharmaceutical, biotech, device and diagnostic companies have found common ground in addressing access issues that have changed the lives of patients all over the world. In this ever-evolving […]
Read the Full Article